Emerald Advisers’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.6M | Sell |
291,692
-2,710
| -0.9% | -$145K | 0.57% | 70 |
|
|
2025
Q1 | $11.9M | Sell |
294,402
-225,712
| -43% | -$9.14M | 0.54% | 75 |
|
|
2024
Q4 | $14.5M | Sell |
520,114
-4,313
| -0.8% | -$120K | 0.56% | 70 |
|
|
2024
Q3 | $15M | Buy |
524,427
+9,175
| +2% | +$263K | 0.58% | 70 |
|
|
2024
Q2 | $12.1M | Sell |
515,252
-23,621
| -4% | -$554K | 0.51% | 72 |
|
|
2024
Q1 | $13.6M | Buy |
538,873
+399,183
| +286% | +$10.1M | 0.55% | 75 |
|
|
2023
Q4 | $3.26M | Buy |
+139,690
| New | +$3.26M | 0.14% | 121 |
|